Moving Beyond ANA: A Smarter Approach to Autoimmune Testing
Autoimmune diseases are among the most complex conditions to diagnose. Symptoms can be vague, overlap across conditions, and vary significantly from one patient to another.
For years, antinuclear antibody (ANA) testing has served as a standard starting point for diagnosis and treatment. However, ANA testing alone often falls short. These antibodies are not always present in autoimmune conditions and can also appear in individuals without disease - leading to inconclusive results, delayed diagnosis, and unnecessary referrals.